ERK MAP kinase signaling in post-mortem brain of suicide subjects: Differential regulation of upstream Raf kinases Raf-1 and B-Raf

Molecular Psychiatry

Volumn 11, Issue 1, 2006, Pages 86-98

  Dwivedi, Y ^a   Rizavi, H S ^a   Conley, R R ^b   Pandey, G N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Catalytic activity; Competitive RT PCR; Depression; Hippocampus; Human; Immunolabeling; Prefrontal cortex; Signal transduction

Indexed keywords

B RAF KINASE; CYCLOPHILIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN;

ADULT; AGE; AGED; ARTICLE; BRAIN; CADAVER; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME REGULATION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHIATRIC DIAGNOSIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUICIDE; VICTIM; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; RNA, MESSENGER; SUICIDE;

EID: 32844458346     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001744     Document Type: Article

References (80)

1. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1331.
2. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999; 286: 1358-1362.
3. Grewal SS, York RD, Stork PJS. Extracellular-signaling-regulated kinase signaling in neurons. Curr Opin Neurobiol 1999; 9: 544-553.
4. Hetman M, Kanning K, Cavanaugh JE, Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 1999; 274: 22569-22680.
5. Impey S, Obrietan K, Storm DR. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 1999; 23: 11-14.
6. Sweatt JD. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 2004; 14: 311-317.
7. Kerkoff E, Rapp UR. Cell cycle targets of Ras/Raf signaling. Oncogene 1998; 17: 1457-1462.
8. Leevers SJ, Paterson HF, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 1994; 369: 411-414.
9. Gomez N, Cohen P. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 1991; 353: 170-173.
10. Jacobs BL, van Praag H, Gage FH. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatr 2000; 5: 262-269.
11. Duman RS. Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatr 2002; 17: 306-310.
12. Charney DS, Manji HK. Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE 2004; re5, [DOI: 10.1126/stke.225].
13. Fossati P, Radtchenko A, Boyer P. Neuroplasticity: from MRI to depressive symptoms. Eur Neuropsychopharmacol 2004; 14: S503-S510.
14. Altschuler DL, Casanova MF, Goldberg TE, Kleinman JE. The hippocampus and parahippocampus in schizophrenia, suicide and control brains. Arch Gen Psychiatr 1990; 47: 1029-1034.
15. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95: 13290-13295.
16. Rajkowska G. Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann NY Acad Sci USA 1997; 836: 253-268.
17. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatr 2000; 48: 766-777.
18. Uno H, Tarara R, Else JG, Suleman MA, Sapolsky RM. Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 1999; 9: 1705-1711.
19. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatr 1999; 45: 1085-1098.
20. Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatr 2000; 48: 755-765.
21. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 2001; 11: 272-280.
22. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophin factor levels in major depressed patients. Psychiatr Res 2002; 109: 143-148.
23. Smith MA, Makino S, Altemus M, Michelson D, Hong SK, Kvetnansky R et al. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc Natl Acad Sci USA 1995; 92: 8788-8792.
24. Smith MA, Makino S, Kvetnansky R, Post RM. Effects of stress on neurotrophic factor expression in the rat brain. Ann NY Acad Sci 1995; 771: 234-239.
25. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatr 2003; 60: 804-815.
26. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22: 3251-3261.
27. Trentani A, Kuipers SD, Ter Horst GJ, Den Boer JA. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology? Eur J Neurosci 2002; 15: 1681-1691.
28. Einat H, Yuan P, Gould TD, Li JL, Du JH, Zhang L et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Soc Neurosci 2003; 23: 7311-7316.
29. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN. Reduced activation and expression of ERK1/2 MAP kinase in the postmortem brain of depressed suicide subjects. J Neurochem 2001; 77: 916-928.
30. Stephens RM, Sithanandam G, Copeland TD, Kaplan DR, Rapp UR, Morrison DK. 95-kilodalton B-Raf serine/threonine kinase: identification of the protein and its major autophosphorylation site. Mol Cell Biol 1992; 12: 3733-3742.
31. Daum G, Eisenmanntappe I, Fries HW, Troppmair J, Rapp UR. The ins and outs of Raf kinases. Trends Biochem Sci 1994; 19: 474-480.
32. Pearson G, Robinson F, Gibson TB, Xu B-E, Karandikar M, Berman K et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001; 22: 153-183.
33. Storm SM, Cleveland JL, Rapp UR. Expression of Raf family proto-oncogenes in normal mouse tissues. Oncogene 1990; 5: 345-351.
34. Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJS. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 1997; 89: 73-82.
35. ras. J Biol Chem 1993; 268: 20232-20236.
36. Kang UG, Jeon SH, Lee JE, Joo Y-H, Yi JS, Park J-B et al. The activation of B-Raf and Raf-1 after electroconvulsive shock in the rat hippocampus. Neuropharmacology 2000; 39: 703-706.
37. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B, Pearson RC. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200: 151-154.
38. Salzman S, Endicott J, Clayton P, Winokur G. Diagnostic Evaluation After Death (DEAD). Rockville, MD: National Institute of Mental Health, Neuroscience Research Branch, 1983.
39. Spitzer RL, Williams JBW, Gibbon M, First MD. Structural Clinical Interview for DSM-IV (SCID), New York State Psychiatric Institute. New York, NY: Biometrics Research, 1995.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folic phenol reagent. J Biol Chem 1951; 193: 266-275.
41. Dwivedi Y, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Alpha subunits of G proteins in the prefrontal cortex of teenage and adult suicide victims. Neuropsychopharmacology 2002; 27: 499-517.
42. Barnier JV, Papin C, Eychene A, Lecoq O, Calothy G. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J Biol Chem 1995; 270: 23381-23389.
43. Sithanandam G, Kolch W, Duh FM, Rapp UR. Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies. Oncogene 1990; 5: 1775-1780.
44. Morice C, Nothias F, Konig S, Vernier P, Baccarini M, Vincent JD et al. Raf-1 and B-Raf proteins have similar regional distributions but differential subcellular localization in adult rat brain. Eur J Neurosci 1999; 11: 1995-2006.
45. Marais R, Light Y, Paterson HF, Marshall CJ. Ras-GTP translocates Raf-1 to the plasma membrane where it becomes phosphorylated on tyrosine residues 340 and 341 by membrane bound tyrosine kinases. EMBO J 1995; 14: 3136-3145.
46. Marais R, Light Y, Paterson HF, Mason CS, Marshall CJ. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic Ras and tyrosine kinases. J Biol Chem 1997; 14: 4378-4383.
47. ras. GMPPNP is dependent on B-Raf. Mol Cell Biol 1994; 14: 7153-7162.
48. Catling AD, Reuter CW, Cox ME, Parsons SJ, Weber MJ. Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf-associated activity. J Biol Chem 1994; 269: 30014-30021.
49. ras. Mol Cell Biol 1994; 14: 6944-6953.
50. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 1998; 392: 622-626.
51. Kao S, Jaiswal RK, Kolch W, Landreth GE. Differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem 2001; 276: 18169-18177.
52. Kolch W. To be or not to be: a question of B-Raf? Trends Neurosci 2001; 24: 498-500.
53. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-185.
54. Yamamori B, Kuroda S, Shimizu K, Fukui K, Ohtsuka T, Takai Y et al. Purification of a Ras-dependent mitogen-activated protein kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. J Biol Chem 1995; 270: 11723-11726.
55. Zwartkruis FJ, Wolthuis RM, Nabben NM, Franke B, Bos JL. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signaling. EMBO J 1998; 17: 5905-5912.
56. Dugan LL, Kim JS, Zhang Y, Bart RD, Sun Y, Holtzman DM et al. Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem 1999; 274: 25842-25848.
57. Dwivedi Y, Rizavi HS, Mondai A, Payappagoudar GV, Conley RR, Pandey GN. Altered expression of Rap1 in postmortem brain of suicide victims. Neuropsycopharmacology 2004; 29(Suppl): 179.
58. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S, Takai Y. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. J Biol Chem 1996; 271: 1258-1261.
59. Okada T, Masuda T, Shinkai M, Kariya K, Kataoka T. Post-transcriptional modifications of H-Ras is required for activation of, but not for association with B-Raf. J Biol Chem 1996; 271: 4671-4678.
60. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998; 282: 2275-2279.
61. de Rooij J, Zwartkruis FJT, Verheijen MHG, Cool RH, Nijman SMB, Wittinghofer A et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998; 396: 474-477.
62. Qiu W, Zhuang S, von Lintig FC, Boss GR, Pilz RB. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J Biol Chem 2000; 275: 31921-31929.
63. 2-adrenergic receptor activates extracellular regulated kinases (ERKs) via the small G protein Rap1 and the serine/threonine kinase B-Raf. J Biol Chem 2002; 275: 25342-25350.
64. Zanassi P, Paolillo M, Feliciello A, Avvedimento EV, Galloand V, Schinelli S. cAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons. J Biol Chem 2001; 276: 11487-11495.
65. Dwivedi Y, Rizavi HS, Shukla PK, Lyons J, Faludi G, Palkovits M et al. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatr 2004; 55: 234-243.
66. Manier DH, Shelton RC, Ellis TC, Peterson CS, Eiring A, Sulser F. Human fibroblasts as a relevant model to study signal transduction in affective disorders. J Affect Disord 2000; 6: 51-58.
67. Shelton RC, Mainer DH, Peterson CS, Ellis TC, Sulser F. Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteers. Int J Neuropsychopharmacol 1999; 2: 187-192.
68. Shelton RC, Mainer DH, Sulser F. cAMP-dependent protein kinase activity in major depression. Am J Psychiatr 1996; 153: 1037-1042.
69. Sheline YI, Warry P, Gado MH, Csernansky JC, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93: 3908-3913.
70. Drevets WC, Gadde KM, Krishman KR. Neuroimaging studies of mood disorders. In: Charney DS, Nestler EJ, Bunney BS (eds.), Neurobiology of Mental Illness. New York: Oxford UP, 1999, pp. 394-418.
71. Drevets WC, Price JL, Simpson Jr JR, Todd RD, Reich T, Vannier M et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386: 824-827.
72. Bremner JD, Narayan M, Anderson ER, Stalb LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatr 2000; 48: 971-975.
73. Benes FM, Kwok EW, Vincent SL, Todtankopf MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatr 1998; 15: 88-97.
74. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatr 2001; 49: 741-752.
75. Adams JP, Sweatt JD. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 2002; 42: 135-163.
76. Feng P, Guan Z, Yang X, Fang J. Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res 2003; 991: 195-205.
77. Mercier G, Lennon AM, Renouf B, Dessouroux A, Ramauge M, Courtin F et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 2004; 24: 207-216.
78. Wiese S, Pei G, Karch C, Troppmair J, Holtmann B, Rapp UR et al. Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons. Nat Neurosci 2001; 4: 137-142.
79. Huser M, Luckett J, Chiloeches A, Mercer K, Iwobi M, Giblett S et al. MEK kinase activity is not necessary for Raf-1 function. EMBO J 2001; 8: 1940-1951.
80. Mikula M, Schreiber M, Husak Z, Kucerova L, Ruth J, Wieser R et al. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J 2001; 8: 1952-1962.